<code id='CF991BE8DE'></code><style id='CF991BE8DE'></style>
    • <acronym id='CF991BE8DE'></acronym>
      <center id='CF991BE8DE'><center id='CF991BE8DE'><tfoot id='CF991BE8DE'></tfoot></center><abbr id='CF991BE8DE'><dir id='CF991BE8DE'><tfoot id='CF991BE8DE'></tfoot><noframes id='CF991BE8DE'>

    • <optgroup id='CF991BE8DE'><strike id='CF991BE8DE'><sup id='CF991BE8DE'></sup></strike><code id='CF991BE8DE'></code></optgroup>
        1. <b id='CF991BE8DE'><label id='CF991BE8DE'><select id='CF991BE8DE'><dt id='CF991BE8DE'><span id='CF991BE8DE'></span></dt></select></label></b><u id='CF991BE8DE'></u>
          <i id='CF991BE8DE'><strike id='CF991BE8DE'><tt id='CF991BE8DE'><pre id='CF991BE8DE'></pre></tt></strike></i>

          Home / fashion / hotspot

          hotspot


          hotspot

          author:entertainment    Page View:4992
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In